Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15314)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 28, 2016 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | González-Grande R, Jiménez-Pérez M, González Arjona C, Mostazo Torres J. New approaches in the treatment of hepatitis C. World J Gastroenterol 2016; 22(4): 1421-1432 [PMID: 26819511 DOI: 10.3748/wjg.v22.i4.1421] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i4/1421.htm |
| Number | Citing Articles |
| 1 |
Clodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, David Saadoun, Anne Claire Desbois, Marco Sebastiani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmunity Reviews 2016; 15(12): 1145 doi: 10.1016/j.autrev.2016.09.006
|
| 2 |
Jonathan Merola, Alexander Z. Jow, Samuel H. Sigal. Principles and Practice of Transplant Infectious Diseases. 2019; : 697 doi: 10.1007/978-1-4939-9034-4_41
|
| 3 |
Juan Turnes, Raquel Domínguez-Hernández, Miguel Ángel Casado. Value and innovation of direct-acting antivirals: long-term health outcomes of the strategic plan for the management of hepatitis C in Spain. Revista Española de Enfermedades Digestivas 2017; doi: 10.17235/reed.2017.5063/2017
|
| 4 |
N. V. Soboleva, A. A. Karlsen, T. V. Kozhanova, V. S. Kichatova, V. V. Klushkina, O. V. Isaeva, M. E. Ignatyeva, VV. .. Romanenko, N. D. Oorzhak, E. Yu. Malinnikova, K. K. Kyuregyan, M. I. Mikhaylov. FREQUENCY OF DETECTION OF ANTIBODIES TO HEPATITIS C VIRUS AMONG CONVENTIONALLY HEALTHY POPULATION OF RUSSIAN FEDERATION. Journal of microbiology, epidemiology and immunobiology 2017; 94(3): 99 doi: 10.36233/0372-9311-2017-3-99-106
|
| 5 |
Rosana Gelpi, Camino Rodríguez-Villar, David Paredes, Rebeca Roque, Angel Ruiz, Ramon Adalia, Erika de Sousa, Ignacio Revuelta, Manuel Sole, Miguel Martinez, Mireia Navarro, Sabela Lens, Federico Oppenheimer, Fritz Diekmann. Safety of hepatitis C virus (HCV)-treated donors for kidney transplantation excluding occult HCV infection through kidney biopsies. Transplant International 2018; 31(8): 938 doi: 10.1111/tri.13270
|
| 6 |
Jessica Cusato, Lucio Boglione, Amedeo De Nicolò, Gian Paolo Caviglia, Simone Mornese Pinna, Alessia Ciancio, Giulia Troshina, Antonina Smedile, Miriam Antonucci, Valeria Avataneo, Alice Palermiti, Jacopo Mula, Alessandra Manca, Giuseppe Cariti, Marco Cantù, Giorgio Maria Saracco, Giovanni Di Perri, Antonio D’Avolio. Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy. Pharmaceuticals 2022; 15(3): 355 doi: 10.3390/ph15030355
|
| 7 |
Afshin A. Anoushiravani, Gokul Kalyanasundaram, James E. Feng, Frank Congiusta, Richard Iorio, Matthew R. DiCaprio. Treating Hepatitis C Prior to Total Hip Arthroplasty is Cost-effective: A Markov Analysis. The Journal of Arthroplasty 2023; 38(7): S84 doi: 10.1016/j.arth.2023.02.067
|
| 8 |
Shanshan Jia, Wei Zhou, Jiarui Wu, Xinkui Liu, Siyu Guo, Jingyuan Zhang, Shuyu Liu, Mengwei Ni, Ziqi Meng, Xiaomeng Zhang, Xiantao Zeng, Zhiwei Jing. A biomolecular network-based strategy deciphers the underlying molecular mechanisms of Bupleuri Radix/ Curcumae Radix medicine pair in the treatment of hepatitis C. European Journal of Integrative Medicine 2020; 33: 101043 doi: 10.1016/j.eujim.2019.101043
|
| 9 |
Antonio Rivero-Juarez, Teresa Brieva, Mario Frias, Antonio Rivero. Pharmacodynamic and pharmacokinetic evaluation of the combination of daclatasvir/sofosbuvir/ribavirin in the treatment of chronic hepatitis C. Expert Opinion on Drug Metabolism & Toxicology 2018; 14(9): 901 doi: 10.1080/17425255.2018.1506765
|
| 10 |
Jessica Cusato, Amedeo De Nicolò, Lucio Boglione, Fabio Favata, Alessandra Ariaudo, Simone Mornese Pinna, Chiara Carcieri, Federica Guido, Valeria Avataneo, Giuseppe Cariti, Giovanni Di Perri, Antonio D’Avolio. Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study. Journal of Antimicrobial Chemotherapy 2018; 73(6): 1659 doi: 10.1093/jac/dky053
|
| 11 |
Abdo A. Elfiky, Eman B. Azzam. Novel guanosine derivatives against MERS CoV polymerase: An in silico perspective. Journal of Biomolecular Structure and Dynamics 2021; 39(8): 2923 doi: 10.1080/07391102.2020.1758789
|
| 12 |
Maria I. Poole, Inmaculada Sorribes, Harsh Vardhan Jain. Modeling hepatitis C virus protein and p53 interactions in hepatocytes: Implications for carcinogenesis. Mathematical Biosciences 2018; 306: 186 doi: 10.1016/j.mbs.2018.10.003
|
| 13 |
Abdo A. Elfiky. Novel Guanosine Derivatives as Anti-HCV NS5b Polymerase: A QSAR and Molecular Docking Study. Medicinal Chemistry 2019; 15(2): 130 doi: 10.2174/1573406414666181015152511
|
| 14 |
Manish Dwivedi, Aditya Dwivedi, Debalina Mukherjee. An Insight into Hepatitis C Virus: In Search of Promising Drug Targets. Current Drug Targets 2023; 24(14): 1127 doi: 10.2174/0113894501265769231020031857
|
| 15 |
Jakub Šimka, Radek Pudil, Monika Fialová, Filip Varhaník, Stanislav Plíšek, Petr Pařízek. Triple Combination with Direct Acting Antivirals in the Treatment of Hepatitis C Does not Prolong the QT Interval. Acta Medica (Hradec Kralove, Czech Republic) 2023; 66(3): 101 doi: 10.14712/18059694.2024.1
|
| 16 |
Teresa Brieva, Antonio Rivero, Antonio Rivero-Juarez. Pharmacokinetic drug evaluation of velpatasvir plus sofosbuvir for the treatment of hepatitis C virus infection. Expert Opinion on Drug Metabolism & Toxicology 2017; 13(4): 483 doi: 10.1080/17425255.2017.1292253
|
| 17 |
Manon Delaplace, Hélène Huet, Adèle Gambino, Sophie Le Poder. Feline Coronavirus Antivirals: A Review. Pathogens 2021; 10(9): 1150 doi: 10.3390/pathogens10091150
|
| 18 |
Abdo A. Elfiky, Alaa Ismail. Molecular dynamics and docking reveal the potency of novel GTP derivatives against RNA dependent RNA polymerase of genotype 4a HCV. Life Sciences 2019; 238: 116958 doi: 10.1016/j.lfs.2019.116958
|
| 19 |
Sumaiah J. Alarfaj, Abdullah Alzahrani, Anfal Alotaibi, Malak Almutairi, Mashael Hakami, Njood Alhomaid, Noori Alharthi, Ghazwa B. Korayem, Abdullah Alghamdi. The effectiveness and safety of direct-acting antivirals for hepatitis C virus treatment: A single-center experience in Saudi Arabia. Saudi Pharmaceutical Journal 2022; 30(10): 1448 doi: 10.1016/j.jsps.2022.07.005
|
| 20 |
Suzanne JF Kaptein, Johan Neyts. Towards antiviral therapies for treating dengue virus infections. Current Opinion in Pharmacology 2016; 30: 1 doi: 10.1016/j.coph.2016.06.002
|
| 21 |
Aila Akosua Kattner. Greek gods and the double-edged sword of liver regeneration. Biomedical Journal 2021; 44(5): 515 doi: 10.1016/j.bj.2021.10.010
|
| 22 |
Waleed Ezzat Madboly, Magdi G. Shehata, Michael Sobhy M. Nashed, Ahmed M. Abu-Dief. Using power of calculated electrons to cut, analyze and exterminate the outer and the inner biological elements of hepatitis C virus without blood parameters disorders: In vitro study: low potential codified ions for hepatitis therapy. Asian Journal of Applied Science and Engineering 2022; 11(1): 45 doi: 10.18034/ajase.v11i1.16
|
| 23 |
Hsien‐Hong Lin, Shih‐Jer Hsu, Sheng‐Nan Lu, Wan‐Long Chuang, Chao‐Wei Hsu, Rong‐Nan Chien, Sien‐Sing Yang, Wei‐Wen Su, Jaw‐Ching Wu, Tzong‐Hsi Lee, Cheng‐Yuan Peng, Kuan‐Chiao Tseng, Albert Qin, Yi‐Wen Huang, Pei‐Jer Chen. Ropeginterferon alfa‐2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy. JGH Open 2021; 5(8): 929 doi: 10.1002/jgh3.12613
|
| 24 |
Miguel García Deltoro, Carmen Ricart Olmos. Infección por el virus de la hepatitis C y nuevas estrategias de tratamiento. Enfermedades Infecciosas y Microbiología Clínica 2019; 37: 15 doi: 10.1016/S0213-005X(19)30177-6
|
| 25 |
Shuvasish Choudhury, Debojyoti Moulick, Anupom Borah, Purbajyoti Saikia, Muhammed Khairujjaman Mazumder. In search of drugs to alleviate suppression of the host's innate immune responses against SARS-CoV-2 using a molecular modeling approach. In Silico Pharmacology 2021; 9(1) doi: 10.1007/s40203-021-00085-y
|
| 26 |
Daniel H. Wiznia, Randall C. Morgan, David Gibson. Movement is Life—Optimizing Patient Access to Total Joint Arthroplasty: HIV and Hepatitis C Disparities. Journal of the American Academy of Orthopaedic Surgeons 2022; 30(21): 1011 doi: 10.5435/JAAOS-D-21-00427
|
| 27 |
Abdo A. Elfiky. Ebola virus glycoprotein GP1—host cell-surface HSPA5 binding site prediction. Cell Stress and Chaperones 2020; 25(3): 541 doi: 10.1007/s12192-020-01106-z
|
| 28 |
Abdo A. Elfiky. Novel guanosine derivatives against Zika virus polymerase in silico. Journal of Medical Virology 2020; 92(1): 11 doi: 10.1002/jmv.25573
|
| 29 |
Stephen Ejeh, Adamu Uzairu, Gideon A. Shallangwa, Stephen E. Abechi. In Silico Design, Drug-Likeness and ADMET Properties Estimation of Some Substituted Thienopyrimidines as HCV NS3/4A Protease Inhibitors. Chemistry Africa 2021; 4(3): 563 doi: 10.1007/s42250-021-00250-y
|
| 30 |
Matthew M. Yeh, Sarag Boukhar, Benjamin Roberts, Nairanjana Dasgupta, Sayed S. Daoud. Genomic variants link to hepatitis C racial disparities. Oncotarget 2017; 8(35): 59455 doi: 10.18632/oncotarget.19755
|
| 31 |
Claudia Westermann, Madeleine Dulon, Dana Wendeler, Albert Nienhaus. Hepatitis C among healthcare personnel: secondary data analyses of costs and trends for hepatitis C infections with occupational causes. Journal of Occupational Medicine and Toxicology 2016; 11(1) doi: 10.1186/s12995-016-0142-5
|
| 32 |
Miguel Jiménez-Pérez, Rocío González-Grande, Pilar España Contreras, Isabel Pinazo Martínez, Jesús de la Cruz Lombardo, Raúl Olmedo Martín. Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance. World Journal of Gastroenterology 2016; 22(29): 6573-6581 doi: 10.3748/wjg.v22.i29.6573
|
| 33 |
Sherief Abd-Elsalam, Yousry Esam-Eldin Abo-Amer, Mohamed El-Abgeegy, Samah A. Elshweikh, Heba Fadl Elsergany, Rehab Ahmed, Mahmoud Elkadeem, Nehad Hawash, Shaimaa Soliman, Rehab Badawi, Ayman Mohammed Abdou Elguindy, Moataz Yousry Soliman, Ahmed Abdelhaleem Mohmed, Loai Mansour. Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease. Medicine 2020; 99(42): e21972 doi: 10.1097/MD.0000000000021972
|
| 34 |
Nikhil Gupta, Tram Tran. Hepatitis C in Pregnancy: Screening and Current Treatments. Current Hepatology Reports 2016; 15(4): 280 doi: 10.1007/s11901-016-0318-6
|
| 35 |
Ahmed Cordie, Aisha Elsharkawy, Shereen Abdel Alem, Safa Meshaal, Wafaa El Akel, Zeinab Abdellatif, Walid Kamal, Mahmoud Al Askalany, Sherif Kamel, Hossam Abdel Aziz, Amr Kandeel, Gamal Esmat. Sustained virologic response and changes in liver fibrosis parameters following 12-wk administration of generic sofosbuvir and daclatasvir in HIV/HCV-coinfected patients with HCV genotype 4 infection. Transactions of The Royal Society of Tropical Medicine and Hygiene 2020; 114(4): 232 doi: 10.1093/trstmh/trz120
|
| 36 |
Gregory D. Huhn, Moti Ramgopal, Mamta K. Jain, Federico Hinestrosa, David M. Asmuth, Jihad Slim, Deborah Goldstein, Shauna Applin, Julie H. Ryu, Shuping Jiang, Stephanie Cox, Moupali Das, Thai Nguyen-Cleary, David Piontkowsky, Bill Guyer, Lorenzo Rossaro, Richard H. Haubrich, Jee-Fu Huang. HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens. PLOS ONE 2020; 15(1): e0224875 doi: 10.1371/journal.pone.0224875
|
| 37 |
Özkan FİDAN. Investigation of Antiviral Potential of Food Carotenoids and Apocarotenoids against RNA-dependent RNA Polymerase of Hepatitis C Virus. Bitlis Eren Üniversitesi Fen Bilimleri Dergisi 2022; 11(3): 931 doi: 10.17798/bitlisfen.1161170
|
| 38 |
Nirmeen Sabry, Ahmed M. Kamel, Ahmed Cordie, Gamal Esmat. Daclatasvir as a hepatitis C infection treatment option: an up-to-date evaluation. Expert Opinion on Pharmacotherapy 2023; 24(2): 159 doi: 10.1080/14656566.2022.2145883
|
| 39 |
Zhenyu Nie, Fengge Zhai, Han Zhang, Haixue Zheng, Jingjing Pei.
The multiple roles of viral 3D
pol
protein in picornavirus infections
. Virulence 2024; 15(1) doi: 10.1080/21505594.2024.2333562
|
| 40 |
Shu-Mei Tsai, Jung-Ta Kao, Yun-Fang Tsai. How hepatitis C patients manage the treatment process of pegylated interferon and ribavirin therapy: a qualitative study. BMC Health Services Research 2016; 16(1) doi: 10.1186/s12913-016-1503-6
|
| 41 |
Sheng Tang, Zong-Gen Peng, Ying-Hong Li, Xin Zhang, Tian-Yun Fan, Jian-Dong Jiang, Yan-Xiang Wang, Dan-Qing Song. Synthesis and biological evaluation of tricyclic matrinic derivatives as a class of novel anti-HCV agents. Chemistry Central Journal 2017; 11(1) doi: 10.1186/s13065-017-0327-8
|
| 42 |
Mihaela‐Olivia Dobrica, André van Eerde, Catalin Tucureanu, Adrian Onu, Lisa Paruch, Iuliana Caras, Ene Vlase, Hege Steen, Sissel Haugslien, Dominic Alonzi, Nicole Zitzmann, Ralph Bock, Jean Dubuisson, Costin‐Ioan Popescu, Crina Stavaru, Jihong Liu Clarke, Norica Branza‐Nichita. Hepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus‐neutralizing activity in vaccinated mice. Plant Biotechnology Journal 2021; 19(10): 2027 doi: 10.1111/pbi.13631
|
| 43 |
Tutik Sri Wahyuni, Humairoh Mahfud, Adita Ayu Permatasari, Aty Widyawaruyanti, Achmad Fuad. Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor. Journal of Basic and Clinical Physiology and Pharmacology 2019; 30(6) doi: 10.1515/jbcpp-2019-0348
|
| 44 |
Zehra Öksüz, Enver Üçbilek, Mehmet Sami Serin, Serkan Yaraş, Gülhan Örekici Temel, Orhan Sezgin. hsa-miR-17-5p: A Possible Predictor of Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir ± Ribavirin Therapy Efficacy in Hepatitis C Infection. Current Microbiology 2022; 79(6) doi: 10.1007/s00284-022-02882-w
|
| 45 |
R. Alonso, F. Pérez-García, D. Ampuero, E. Reigadas, E. Bouza. New direct-acting antivirals for patients with chronic HCV infection: can we monitor treatment using an HCV core antigen assay?. Diagnostic Microbiology and Infectious Disease 2017; 87(3): 243 doi: 10.1016/j.diagmicrobio.2016.11.010
|
| 46 |
Amira F. El-Yazbi, Nourhan E. Elashkar, Hytham M. Ahmed, Wael Talaat, Karim M. Abdel-Hay. Cost-effective green chromatographic method for the simultaneous determination of four commonly used direct-acting antiviral drugs in plasma and various pharmaceutical formulations. Microchemical Journal 2021; 168: 106512 doi: 10.1016/j.microc.2021.106512
|
| 47 |
Jingbo Yang. Hepatitis C Risk Prediction Based on Adaboost. Highlights in Science, Engineering and Technology 2023; 54: 413 doi: 10.54097/hset.v54i.9803
|
| 48 |
Jessica Cusato, Lucio Boglione, Amedeo De Nicolò, Fabio Favata, Alessandra Ariaudo, Simone Mornese Pinna, Federica Guido, Valeria Avataneo, Marco Cantù, Chiara Carcieri, Giuseppe Cariti, Giovanni Di Perri, Antonio D’Avolio. Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs. Cancer Chemotherapy and Pharmacology 2018; 81(3): 615 doi: 10.1007/s00280-018-3520-0
|
| 49 |
Jessica Cusato, Amedeo De Nicolò, Lucio Boglione, Fabio Favata, Alessandra Ariaudo, Simone Mornese Pinna, Chiara Carcieri, Federica Guido, Valeria Avataneo, Giuseppe Cariti, Giovanni Di Perri, Antonio D'Avolio. Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients. Infection, Genetics and Evolution 2018; 60: 42 doi: 10.1016/j.meegid.2018.02.016
|
| 50 |
R. Schwarzkopf, D. Novikov, A. A. Anoushiravani, J. E. Feng, J. Vigdorchik, B. Schurko, M. K. Dwyer, H. S. Bedair. The preoperative management of Hepatitis C may improve the outcome after total knee arthroplasty. The Bone & Joint Journal 2019; (6): 667 doi: 10.1302/0301-620X.101B6.BJJ-2018-0723.R3
|
| 51 |
Mario Frías, Antonio Rivero-Juárez, Isabel Machuca, Ángela Camacho, Antonio Rivero. The outlook for precision medicine for the treatment of chronic hepatitis C infection: challenges and opportunities. Expert Review of Precision Medicine and Drug Development 2020; 5(4): 253 doi: 10.1080/23808993.2020.1764346
|
| 52 |
Ying-Hong Li, Zhou-Yi Wu, Sheng Tang, Xin Zhang, Yan-Xiang Wang, Jian-Dong Jiang, Zong-Gen Peng, Dan-Qing Song. Evolution of matrinic ethanol derivatives as anti-HCV agents from matrine skeleton. Bioorganic & Medicinal Chemistry Letters 2017; 27(9): 1962 doi: 10.1016/j.bmcl.2017.03.025
|
| 53 |
Tung Huynh, Johnathan Zhang, Ke-Qin Hu. Hepatitis C Virus Clearance by Direct-acting Antiviral Results in Rapid Resolution of Hepatocytic Injury as Indicated by Both Alanine Aminotransferase and Aspartate Aminotransferase Normalization. Journal of Clinical and Translational Hepatology 2018; 6(3): 1 doi: 10.14218/JCTH.2018.00014
|
| 54 |
Roberto Nuño Solinís, Patricia Arratibel Ugarte, Ander Rojo, Yuri Sanchez Gonzalez. Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence. Infectious Diseases and Therapy 2016; 5(4): 491 doi: 10.1007/s40121-016-0134-x
|
| 55 |
Yeba H. Adje, Kristina M. Brooks, Jose R. Castillo-Mancilla, David L. Wyles, Peter L. Anderson, Jennifer J. Kiser. The use of technology-based adherence monitoring in the treatment of hepatitis C virus. Therapeutic Advances in Infectious Disease 2022; 9: 204993612210956 doi: 10.1177/20499361221095664
|
| 56 |
Stephen Ejeh, Adamu Uzairu, Gideon Adamu Shallangwa, Stephen E. Abechi. Computer-aided identification of a series of novel ligands showing high potency as hepatitis C virus NS3/4A protease inhibitors. Bulletin of the National Research Centre 2021; 45(1) doi: 10.1186/s42269-020-00467-w
|
| 57 |
Tutik Sri Wahyuni, Chie Aoki Utsubo, Hak Hotta. Promising Anti-Hepatitis C Virus Compounds from Natural Resources. Natural Product Communications 2016; 11(8): 1934578X1601100 doi: 10.1177/1934578X1601100840
|
| 58 |
Axel Pruß, Akila Chandrasekar, Jacinto Sánchez-Ibáñez, Sophie Lucas-Samuel, Ulrich Kalus, Holger F. Rabenau. Algorithms for the Testing of Tissue Donors for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus. Transfusion Medicine and Hemotherapy 2021; 48(1): 12 doi: 10.1159/000513179
|
| 59 |
Dapeng Li, Markus von Schaewen, Xuesong Wang, Wanyin Tao, Yunfang Zhang, Li Li, Brigitte Heller, Gabriela Hrebikova, Qiang Deng, Alexander Ploss, Jin Zhong, Zhong Huang, M. S. Diamond. Altered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in Mice. Journal of Virology 2016; 90(23): 10486 doi: 10.1128/JVI.01462-16
|
| 60 |
|
| 61 |
A. Abdel Moneim, H. A. Suleiman, B. Mahmoud, D. Mabrouk, M. Y. Zaky, B. Mahmoud. Viral clearance ameliorates hematological and inflammatory markers among diabetic patients infected with hepatitis C genotype 4. Clinical and Experimental Medicine 2020; 20(2): 231 doi: 10.1007/s10238-019-00605-3
|
| 62 |
Michael K. Turgeon, Shimul A. Shah, Aaron M. Delman, Benjamin V. Tran, Vatche G. Agopian, Joel P. Wedd, Joseph F. Magliocca, Ahyoung Kim, Andrew Cameron, Ali Olyaei, Susan L. Orloff, Matthew P. Anderson, Chandrashekhar A. Kubal, Robert M. Cannon, Jayme E. Locke, Mary A. Simpson, Mohamed E. Akoad, Chelsey P. Wongjirad, Juliet Emamaullee, Amika Moro, Federico Aucejo, Cyrus A. Feizpour, Parsia A. Vagefi, Mindie H. Nguyen, Carlos O. Esquivel, Kiran Dhanireddy, Vijay Subramanian, Alejandro Chavarriaga, Marwan M. Kazimi, Maia S. Anderson, Christopher J. Sonnenday, Steven C. Kim, David P. Foley, Marwan Abdouljoud, Reena J. Salgia, Dimitrios Moris, Debra L. Sudan, Swaytha R. Ganesh, Abhinav Humar, Majella Doyle, William C. Chapman, Shishir K. Maithel. Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation. Annals of Surgery 2021; 274(4): 613 doi: 10.1097/SLA.0000000000005070
|
| 63 |
Qiu-Feng He, Qiong-Fang Zhang, Da-Zhi Zhang. Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis. Digestive Diseases and Sciences 2016; 61(11): 3108 doi: 10.1007/s10620-016-4291-2
|
| 64 |
Abdo A Elfiky. Zika virus: novel guanosine derivatives revealed strong binding and possible inhibition of the polymerase. Future Virology 2017; 12(12): 721 doi: 10.2217/fvl-2017-0081
|
| 65 |
Bing Gao, Dongdong Zhao, Lingmu Li, Zhigang Cheng, Ye Guo. Antiviral Peptides with in vivo Activity: Development and Modes of Action. ChemPlusChem 2021; 86(12): 1547 doi: 10.1002/cplu.202100351
|
| 66 |
Rocío González Grande, Inmaculada Santaella Leiva, Susana López Ortega, Miguel Jiménez Pérez. Present and future management of viral hepatitis. World Journal of Gastroenterology 2021; 27(47): 8081-8102 doi: 10.3748/wjg.v27.i47.8081
|
| 67 |
J. Bagg, K. Roy, L. Hopps, I. Black, D. Croser, C. O'Halloran, F. Ncube. No longer 'written off' – times have changed for the BBV-infected dental professional. British Dental Journal 2017; 222(1): 47 doi: 10.1038/sj.bdj.2017.36
|
| 68 |
Muhammad H. Bashir, Javid Fazili, Mohammad F. Madhoun, Rajesh Kanagala, Sixia Chen, Salman Nusrat. Impact of sustained virologic response on short-term clinical outcomes in hepatitis C-related cirrhosis. European Journal of Gastroenterology & Hepatology 2018; 30(3): 296 doi: 10.1097/MEG.0000000000001032
|
| 69 |
Ying Yang, Feng-Ping Wu, Wen-Jun Wang, Juan-Juan Shi, Ya-Ping Li, Xin Zhang, Shuang-Suo Dang. Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China. World Journal of Gastroenterology 2019; 25(44): 6551-6560 doi: 10.3748/wjg.v25.i44.6551
|
| 70 |
Victoria Green, Marina Roytman, Haruki Komatsu. Treatment-Resistant Hepatitis C Viral Infection: A Case Report and Literature Review. Case Reports in Hepatology 2022; 2022: 1 doi: 10.1155/2022/3556780
|
| 71 |
Jessica Cusato, Amedeo De Nicolò, Lucio Boglione, Fabio Favata, Alessandra Ariaudo, Simone Mornese Pinna, Federica Guido, Valeria Avataneo, Chiara Carcieri, Giuseppe Cariti, Giovanni Di Perri, Antonio D’Avolio. Influence of ABCB11 and HNF4α genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study. Journal of Antimicrobial Chemotherapy 2017; 72(10): 2846 doi: 10.1093/jac/dkx237
|
| 72 |
Amitava Dasgupta, Amer Wahed. Clinical Chemistry, Immunology and Laboratory Quality Control. 2021; : 513 doi: 10.1016/B978-0-12-815960-6.00015-7
|
| 73 |
Catalina Mira, Jesús Orlando Yepes, Luis Felipe Henao, Melissa Montoya Guzmán, Maria-Cristina Navas. EXPRESIÓN DE LA PROTEÍNA CORE DEL VIRUS DE LA HEPATITIS C EN CÉLULAS HEPG2 USANDO EL VIRUS DEL BOSQUE DE SEMLIKI. Acta Biológica Colombiana 2020; 26(1): 72 doi: 10.15446/abc.v26n1.79365
|
| 74 |
Vaishali M. Patil, Neeraj Masand, Satya P. Gupta. Viral Polymerases. 2019; : 357 doi: 10.1016/B978-0-12-815422-9.00013-9
|
| 75 |
Yael Gozlan, Efrat Bucris, Rachel Shirazi, Avia Rakovsky, Ziv Ben-Ari, Yana Davidov, Ella Veizman, Tarek Saadi, Marius Braun, Michal Cohen-Naftaly, Amir Shlomai, Oren Shibolet, Ehud Zigmond, Helena Katchman, Yoram Menachem, Rifaat Safadi, Eitan Galun, Eli Zuckerman, Assy Nimer, Rawi Hazzan, Yaakov Maor, Abu Moch Saif, Ohad Etzion, Yoav Lurie, Ella Mendelson, Orna Mor. High Frequency of Multiclass HCV Resistance-Associated Mutations in Patients Failing Direct-Acting Antivirals: Real-Life Data. Antiviral Therapy 2019; 24(3): 221 doi: 10.3851/IMP3301
|
| 76 |
David Novikov, James E. Feng, Afshin A. Anoushiravani, Jonathan M. Vigdorchik, Claudette M. Lajam, Thorsten M. Seyler, Ran Schwarzkopf. Undetectable Hepatitis C Viral Load Is Associated With Improved Outcomes Following Total Joint Arthroplasty. The Journal of Arthroplasty 2019; 34(12): 2890 doi: 10.1016/j.arth.2019.06.058
|
| 77 |
Mario Frias, Antonio Rivero-Juárez, Pedro López-López, Antonio Rivero. Pharmacogenetics and the treatment of HIV-/HCV-coinfected patients. Pharmacogenomics 2018; 19(12): 979 doi: 10.2217/pgs-2018-0046
|
| 78 |
Nikita Chadha, Alan Turner, Richard K. Sterling. Prevalence and predictors of abnormal alanine aminotransferase in patients with HCV who have achieved SVR. Journal of Viral Hepatitis 2023; 30(1): 73 doi: 10.1111/jvh.13763
|
| 79 |
Vasil B. Krapchev, Malgorzata Rychłowska, Alicja Chmielewska, Karolina Zimmer, Arvind H. Patel, Krystyna Bieńkowska-Szewczyk. Recombinant Flag-tagged E1E2 glycoproteins from three hepatitis C virus genotypes are biologically functional and elicit cross-reactive neutralizing antibodies in mice. Virology 2018; 519: 33 doi: 10.1016/j.virol.2018.03.026
|
| 80 |
Giovanni Damiani, Chiara Franchi, Paolo Pigatto, Andrea Altomare, Alessia Pacifico, Stephen Petrou, Sebastiano Leone, Maria Caterina Pace, Marco Fiore. Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents. World Journal of Hepatology 2018; 10(2): 329-336 doi: 10.4254/wjh.v10.i2.329
|
| 81 |
Abdo A. Elfiky. Zika viral polymerase inhibition using anti‐HCV drugs both in market and under clinical trials. Journal of Medical Virology 2016; 88(12): 2044 doi: 10.1002/jmv.24678
|
| 82 |
Francisca Cuenca-Lopez, Antonio Rivero, Antonio Rivero-Juárez. Pharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis C. Expert Opinion on Drug Metabolism & Toxicology 2017; 13(1): 105 doi: 10.1080/17425255.2017.1255725
|
| 83 |
Daniel Bodek, Pavan Patel, Sushil Ahlawat, Evan Orosz, Thayer Nasereddin, Nikolaos Pyrsopoulos. Superior Performance of Teaching and Transplant Hospitals in the Management of Hepatic Encephalopathy from 2007 to 2014. Journal of Clinical and Translational Hepatology 2018; 7(1): 1 doi: 10.14218/JCTH.2017.00078
|
| 84 |
Ena Pavelic, Vladimir Blagaic, Paulo Zekan, Petra Glad Stritof, Mara Bebek, Josko Bilandzic, Milan Pavlovic, Mihovil Herceg, Melanie Deutsch. Occurrence of Liver Damage and Obstetric Outcomes in Pregnant Women Diagnosed with Pruritus during Pregnancy: A Retrospective Study. International Journal of Clinical Practice 2022; 2022: 1 doi: 10.1155/2022/5913712
|
| 85 |
Maria Lorena Abate, Gian Paolo Caviglia. Chronic Hepatitis C: Pathophysiology and Clinical Issues. Biology 2022; 11(12): 1737 doi: 10.3390/biology11121737
|
| 86 |
Claudia Westermann, Dana Wendeler, Albert Nienhaus. Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents. Journal of Occupational Medicine and Toxicology 2018; 13(1) doi: 10.1186/s12995-018-0197-6
|
| 87 |
Luis Gutiérrez-Rojas, Jesús José de la Gándara Martín, Luisa García Buey, Juan I. Uriz Otano, Álvaro Mena, Carlos Roncero. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review. Gastroenterología y Hepatología (English Edition) 2023; 46(5): 382 doi: 10.1016/j.gastre.2022.06.009
|
| 88 |
Sofija Sekulic, Zeljko Mijailovic, Dejan Petrovic, Ruzica Lukic, Marina Jovanovic, Ivan Jovanovic. HCV Infection and Chronic Renal Disease. Serbian Journal of Experimental and Clinical Research 2021; 0(0) doi: 10.2478/sjecr-2021-0010
|
| 89 |
Aila Akosua Kattner. One day at a time. Biomedical Journal 2021; 44(6): S1 doi: 10.1016/j.bj.2022.01.009
|
| 90 |
Richard A. Urbanowicz, Ruixue Wang, John E. Schiel, Zhen-yong Keck, Melissa C. Kerzic, Patrick Lau, Sneha Rangarajan, Kyle J. Garagusi, Lei Tan, Johnathan D. Guest, Jonathan K. Ball, Brian G. Pierce, Roy A. Mariuzza, Steven K. H. Foung, Thomas R. Fuerst, J.-H. James Ou. Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells. Journal of Virology 2019; 93(7) doi: 10.1128/JVI.01403-18
|
| 91 |
Claudia Westermann, Dana Wendeler, Albert Nienhaus. Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents. Journal of Occupational Medicine and Toxicology 2021; 16(1) doi: 10.1186/s12995-021-00320-4
|
| 92 |
Phillip E. Ross, Joseph R. Young, Casey M. O’Connor, Afshin A. Anoushiravani, Matthew R. DiCaprio. Perioperative Management of Hepatitis C in Patients Undergoing Total Joint Arthroplasty. JBJS Reviews 2021; 9(11) doi: 10.2106/JBJS.RVW.20.00223
|
| 93 |
Izabela Ciaston, Ewelina Dobosz, Jan Potempa, Joanna Koziel. The subversion of toll-like receptor signaling by bacterial and viral proteases during the development of infectious diseases. Molecular Aspects of Medicine 2022; 88: 101143 doi: 10.1016/j.mam.2022.101143
|
| 94 |
CARINA S. LIBRELOTTO, ANA PAULA DE SOUZA, MÁRIO R. ÁLVARES-DA-SILVA, DANIEL SIMON, RAFAEL R. DIHL. Evaluation of the genetic toxicity of sofosbuvir and simeprevir with and without ribavirin in a human-derived liver cell line. Anais da Academia Brasileira de Ciências 2021; 93(4) doi: 10.1590/0001-3765202120200632
|
| 95 |
Bernard Esquivel. Pharmacogenomics in Clinical Practice. 2023; : 271 doi: 10.1007/978-3-031-45903-0_15
|
| 96 |
Luis Gutiérrez-Rojas, Jesús José de la Gándara Martín, Luisa García Buey, Juan I. Uriz Otano, Álvaro Mena, Carlos Roncero. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review. Gastroenterología y Hepatología 2023; 46(5): 382 doi: 10.1016/j.gastrohep.2022.06.001
|
| 97 |
Elia Moreno-Cubero, Juan-Ramón Larrubia. Specific CD8<sup>+</sup> T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis. World Journal of Gastroenterology 2016; 22(28): 6469-6483 doi: 10.3748/wjg.v22.i28.6469
|
| 98 |
Carina Sperotto Librelotto, Daniel Simon, Ana Paula de Souza, Mário Reis Álvares-da-Silva, Rafael Rodrigues Dihl. Chromosomal instability and cytotoxicity induced by ribavirin: comparative analysis in cell lines with different drug-metabolizing profiles. Drug and Chemical Toxicology 2019; 42(4): 343 doi: 10.1080/01480545.2017.1405970
|
| 99 |
Valentina Pecoraro, Rita Banzi, Elisabetta Cariani, Johanna Chester, Erica Villa, Roberto D'Amico, Vittorio Bertele', Tommaso Trenti. New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled Trials. Journal of Clinical and Experimental Hepatology 2019; 9(4): 522 doi: 10.1016/j.jceh.2018.07.004
|
| 100 |
N. V. Vlasenko, T. A. Loscutova, K. O. Mironov, A. S. Esman, E. A. Dunaeva, T. A. Semenenko, D. B. Dubodelov, M. I. Korabelnikova, Z. B. Ponezheva, V. V. Makashova, K. G. Omarova, A. V. Sacuk, G. G. Solopova, S. N. Kuzin, V. G. Akimkin. Genetic Factors for the Natural Elimination of Hepatitis C Virus. Epidemiology and Vaccinal Prevention 2023; 22(2): 55 doi: 10.31631/2073-3046-2023-22-2-55-65
|
| 101 |
Babita Agrawal, Rakesh Kumar. Symbiotic chemo- and immuno-therapy for hepatitis B and C viruses. World Journal of Gastroenterology 2016; 22(25): 5623-5626 doi: 10.3748/wjg.v22.i25.5623
|
| 102 |
Wael Elshemey, Ibrahim M. Ibrahim, Abdo A. Elfiky, Alaa M. Elgohary. Prediction of HCV E2 association with the host-cell chaperone, GRP78. Informatics in Medicine Unlocked 2023; 39: 101257 doi: 10.1016/j.imu.2023.101257
|